Atualização no manejo da dor musculoesquelética

André Wan Wen Tsai; Ricardo Kobayashi; Ibrahim Afrânio Willi Liu; Márcio Fim; André Cicone Liggieri; Edilson Silva Machado

doi:10.1055/s-0043-1776135

Revista Brasileira de Ortopedia, Table of Contents

CC BY 4.0 · Rev Bras Ortop (Sao Paulo) 2024; 59(02): e160-e171
DOI: 10.1055/s-0043-1776135

Artigo de Atualização

Dor

Atualização no manejo da dor musculoesquelética

Article in several languages: português | English

Authors

André Wan Wen Tsai

¹Colégio Médico de Acupuntura do Estado de SP, São Paulo, SP, Brasil
Ricardo Kobayashi

²Centro de Dor, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil
Ibrahim Afrânio Willi Liu

³Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil
Márcio Fim

⁴Cirurgia de Ombro e Cotovelo, Instituto de Previdência dos Servidores do Estado de Minas Gerais (IPSEMG), Belo Horizonte, MG, Brasil
André Cicone Liggieri

²Centro de Dor, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil
Edilson Silva Machado

⁵Serviço de Dor e Cuidados Paliativos, Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brasil

Abstract

Resumo

A dor é a queixa mais comum recebida pelo ortopedista no ambulatório e/ou emergência. Inúmeras publicações relatam o manejo inadequado tanto da dor aguda quanto da dor crônica pelos profissionais da saúde. O objetivo desse artigo de atualização é trazer informações sobre a dor musculoesquelética, sua classificação, avaliação, diagnóstico e abordagem terapêutica multimodal para cada situação. Desta maneira, nas dores agudas seu controle adequado possibilita um trabalho de reabilitação mais precoce, bem como diminui os índices de cronificação da dor. Nas dores crônicas sua abordagem além da diminuição de sua intensidade, visa também melhorar a qualidade de vida. Atualmente alguns procedimentos estão sendo cada vez mais utilizados com auxílio de aparato de imagem com objetivo diagnóstico e terapêutico.

Palavras-chave

dor aguda - dor crônica - dor musculoesquelética - manejo da dor - dor pós-operatória

Full Text

References

Referências
1 Rice ASC, Smith BH, Blyth FM. Pain and the global burden of disease. Pain 2016; 157 (04) 791-796
2 Henschke N, Kamper SJ, Maher CG. The epidemiology and economic consequences of pain. Mayo Clin Proc 2015; 90 (01) 139-147
3 Raja SN, Carr DB, Cohen M. et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 2020; 161 (09) 1976-1982
4 Chapman CR, Vierck CJ. The Transition of Acute Postoperative Pain to Chronic Pain: An Integrative Overview of Research on Mechanisms. J Pain 2017; 18 (04) 359.e1-359.e38
5 Woller SA, Eddinger KA, Corr M, Yaksh TL. An overview of pathways encoding nociception. Clin Exp Rheumatol 2017; 35 (5, Suppl 107) 40-46
6 Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet 2021; 397 (10289): 2082-2097
7 Aguiar DP, Souza CP, Barbosa WJ, Santos-Júnior FF, Oliveira AS. Prevalência de dor crônica no Brasil: revisão sistemática. BrJP São Paulo 2021; 4 (03) 257-267
8 Fletcher D, Stamer UM, Pogatzki-Zahn E. et al; euCPSP group for the Clinical Trial Network group of the European Society of Anaesthesiology. Chronic postsurgical pain in Europe: An observational study. Eur J Anaesthesiol 2015; 32 (10) 725-734
9 Treede RD, Rief W, Barke A. et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160 (01) 19-27
10 Chou R, Gordon DB, de Leon-Casasola OA. et al. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016; 17 (02) 131-157
11 Merskey H, Bogduk N. , Eds. Classification of chronic pain descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle (WA): International Association for the Study of Pain; 1994
12 Moisset X, Bouhassira D, Avez Couturier J. et al. Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations. Rev Neurol (Paris) 2020; 176 (05) 325-352
13 Heller GZ, Manuguerra M, Chow R. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance. Scand J Pain 2016; 13: 67-75
14 VanDenKerkhof EG, Stitt L, Clark AJ. et al. Sensitivity of the DN4 in Screening for Neuropathic Pain Syndromes. Clin J Pain 2018; 34 (01) 30-36
15 Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001; 92 (1-2): 147-157
16 Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22 (10) 1911-1920
17 World Health Organization. Cancer pain relief. Geneva Albany, NY: World Health Organization; ; WHO Publications Center USA distributor; 1986
18 Yang J, Bauer BA, Wahner-Roedler DL, Chon TY, Xiao L. The Modified WHO Analgesic Ladder: Is It Appropriate for Chronic Non-Cancer Pain?. J Pain Res 2020; 13: 411-417
19 Crews JC. Multimodal pain management strategies for office-based and ambulatory procedures. JAMA 2002; 288 (05) 629-632
20 Rezende RM, França DS, Menezes GB, dos Reis WG, Bakhle YS, Francischi JN. Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Br J Pharmacol 2008; 153 (04) 760-768
21 Lorenzetti BB, Ferreira SH. Mode of analgesic action of dipyrone: direct antagonism of inflammatory hyperalgesia. Eur J Pharmacol 1985; 114 (03) 375-381
22 Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376 (9736) 190-201
23 Hamerschlak N, Maluf E, Biasi Cavalcanti A. et al. Incidence and risk factors for agranulocytosis in Latin American countries–the Latin Study: a multicenter study. Eur J Clin Pharmacol 2008; 64 (09) 921-929
24 Sakata RK, Nunes MHG. Analgesics use for kidney failure. Rev Dor 2014; 15 (03) 224-229
25 Schug SA. Clinical pharmacology of non-opioid and opioid analgesics. In: Justins DM. , editor. Pain 2005–An Up- date Review: Refresher Course Syllabus. Seattle: IASP Press; 2005: 31-40
26 Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999; 106 (5B): 13S-24S
27 Busse JW, Wang L, Kamaleldin M. et al. Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis. JAMA 2018; 320 (23) 2448-2460
28 Kraychete DC, Siqueira JTT, Zakka TRM, Garcia JBS. Recommendations for the use of opioids in Brazil: Part III. Use in special situations (postoperative pain, musculoskeletal pain, neuropathic pain, gestation and lactation). Rev Dor 2014; 15 (02) 126-132
29 Kraychete DC, Sakata RK. Use and rotation of opioids in chronic non-oncologic pain. Rev Bras Anestesiol 2012; 62 (04) 554-562
30 Kraychete DC, Garcia JBS, Siqueira JTT. Recommendations for the use of opioids in Brazil: Part IV. Adverse opioid effects. Rev Dor 2014; 15 (03) 215-223
31 García CA, Santos Garcia JB, Rosario Berenguel Cook MD. et al. Undertreatment of pain and low use of opioids in Latin America. Pain Manag (Lond) 2018; 8 (03) 181-196
32 Lee CR, McTavish D, Sorkin EM. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993; 46 (02) 313-340
33 King S, Forbes K, Hanks GW, Ferro CJ, Chambers EJ. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med 2011; 25 (05) 525-552
34 Vree TB, van Dongen RT, Koopman-Kimenai PM. Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int J Clin Pract 2000; 54 (06) 395-398
35 Gong QL, Hedner T, Hedner J, Björkman R, Nordberg G. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol 1991; 193 (01) 47-56
36 Kobayashi R, Luzo MVM, Cohen M. Tratado de dor musculoesquelética. São Paulo: Alef; 2019
37 Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther 2006; 79 (05) 461-479
38 Dalal S, Chitneni A, Berger AA. et al. Buprenorphine for chronic pain: A safer alternative to traditional opioids. Health Psychol Res 2021; 9 (01) 27241
39 Alshehri FS. Tapentadol: A review of experimental pharmacology studies, clinical trials, and recent findings. Drug Des Devel Ther 2023; 17: 851-861
40 Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ. Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. Eur J Pain 2017; 21 (02) 228-237
41 van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003; 2003 (02) CD004252
42 Finnerup NB, Attal N, Haroutounian S. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14 (02) 162-173
43 Attal N. Pharmacological treatments of neuropathic pain: The latest recommendations. Rev Neurol (Paris) 2019; 175 (1-2): 46-50
44 Hainline B, Derman W, Vernec A. et al. International Olympic Committee consensus statement on pain management in elite athletes. [published correction appears in Br J Sports Med. 2018 Jan 3;] Br J Sports Med 2017; 51 (17) 1245-1258
45 Sabatschus I, Bösl I, Prevoo M. et al. Comparative Benefit-Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach. Pain Ther 2022; 11 (01) 73-91
46 Menezes MS, Sakata RK, Issy AM. Anticonvulsivantes. In: Sakata RK, Issy AM. , editores. Fármacos para tratamento da dor. Barueri, SP: Manole; 2008: 111-138
47 Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004; 45 (Suppl. 06) 13-18
48 Gammaitoni AR, Alvarez NA, Galer BS. Pharmacokinetics and safety of continuously applied lidocaine patches 5%. Am J Health Syst Pharm 2002; 59 (22) 2215-2220
49 Überall MA, Eerdekens M, Hollanders E, Bösl I, Sabatschus I. Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry. Pain Manag (Lond) 2022; 12 (02) 195-209
50 Derry S, Wiffen PJ, Kalso EA. et al. Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews. Cochrane Database Syst Rev 2017; 5 (05) CD008609
51 Bannuru RR, Osani MC, Vaysbrot EE. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019; 27 (11) 1578-1589
52 Liggieri VC, Yeng LT, Teixeira MJ. , Eds. Tratado de dor, reabilitação e atividade física: Conceitos e prática clínica. São Paulo: Editora dos Editores; 2022
53 Centeno CJ, Williams CJ, Hyzy M. Interventional orthopedics in pain medicine practice. Tech Reg Anesth Main Manag 2015; 19 (1–2): 26-31
54 Braun L, Braun L. Técnicas intervencionistas no tratamento da dor. Cienc Cult 2011; 63 (01) 49-50
55 Korbe S, Udoji EN, Ness TJ, Udoji MA. Ultrasound-guided interventional procedures for chronic pain management. Pain Manag (Lond) 2015; 5 (06) 465-482
56 Lin J. Platelet-rich plasma injection in the treatment of frozen shoulder: A randomized controlled trial with 6-month follow-up . Int J Clin Pharmacol Ther 2018; 56 (08) 366-371
57 McCormick ZL, Reddy R, Korn M. et al. A prospective randomized trial of prognostic genicular nerve blocks to determine the predictive value for the outcome of cooled radiofrequency ablation for chronic knee pain due to osteoarthritis. Pain Med 2018; 19 (08) 1628-1638